GlassScriptPhysician profile
Toshitaka Hoppo
NPI 1154589885
$66,003.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $9,059 · 2021: $4,130 · 2022: $23K · 2023: $5,674 · 2024: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,095 · Travel and Lodging: $1,503 · Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,095.14 |
| Travel and Lodging | $1,503.42 |
| Food and Beverage | $587.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $35,909.51 | 2019-2024 | |
| Ethicon US, LLC | $22,790.57 | 2019-2024 | Linx Reflux Management System, Linx Reflux Management System |
| Intuitive Surgical, INC. | $6,185.13 | 2021-2023 | Da Vinci Surgical System |
| Musculoskeletal Transplant Foundation INC. | $299.62 | 2020 | |
| Pinnacle Biologics, INC | $286.94 | 2021-2022 | |
| Covidien LP | $220.12 | 2019 | |
| Laborie Medical Technologies Corp. | $122.92 | 2024 | Alphaone |
| Genzyme Corporation | $62.43 | 2023 | |
| Boston Scientific Corporation | $51.48 | 2020-2022 | |
| Medtronic, INC. | $27.98 | 2022 | |
| Cook Medical LLC | $25.63 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toshitaka Hoppo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.